1. Vertex Has "Significant Financial Firepower"  Yahoo Finance
2. Vertex Pharmaceuticals Incorporated (VRTX): A Good Value At Its Current Share Price  TechnoRecorder
3. Winning At The Stock Market Table: Vertex Pharmaceuticals Incorporated (VRTX), National Fuel Gas Company (NFG)  US Post News
4. Vertex Pharmaceuticals Incorporated (VRTX): All the Basics You Need to Know  The News Heater
5. Vertex Pharmaceuticals Incorporated (VRTX): Long-Term Gains Looking More Likely  Finch News
6. View full coverage on Google News

Vertex, known for cystic fibrosis drugs, sets its sights on taming pain  STAT

Known for treating cystic fibrosis, Vertex is making progress in developing a new class of drugs for a more commone malady: pain.

Should You Worry About Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) CEO Salary Level?  Yahoo Finance

Jeffrey Leiden has been the CEO of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) since 2012. This report will, first, examine the CEO compensation ...

Vertex Pharmaceuticals Stock Soared on a Strong Earnings Report  Barron's

Shares of the biotech firm Vertex Pharmaceuticals jumped 7.6% on Thursday, after the company released earnings Wednesday afternoon that exceeded ...

Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals  Yahoo Finance

Alexion Pharmaceuticals (NASDAQ: ALXN) and Vertex Pharmaceuticals (NASDAQ: VRTX) rank as two of the most successful biotechs focused on rare diseases ...

Will This Asteroid Heading Toward Vertex Pharmaceuticals Make Impact?  Yahoo Finance

Find out how concerned Vertex investors should be about a potential new cystic fibrosis treatment.

Vertex touts Symdeko success in face of CEO turnover, Orkambi stumble  FiercePharma

With a new CEO stepping in to steer the ship, some have wondered whether the move could lead to a slowdown at Vertex. The company's response? We're still ...

FDA decision on Vertex's CF triple will come just ahead of planned CEO shakeup  Endpoints News

FDA regulators have set a PDUFA date of March 19, 2020, just a year after the Boston biotech posted positive Phase III results showing that people with two ...

Vertex's planned CEO handoff could signal stagnant growth to come: analyst  FiercePharma

SVB Leerink analysts have a number of concerns about Vertex's plan to hand the CEO job to Reshma Kewalramani, not the least of which is whether she has ...

Vertex (VRTX) to Post Q2 Earnings: What's in the Cards?  Yahoo Finance

Vertex Pharmaceuticals Inc. VRTX is scheduled to report second-quarter 2019 earnings results on Jul 31, 2019, after the market closes. Shares of Vertex have ...

The Zacks Analyst Blog Highlights: Celgene, Gilead, Vertex, Sarepta and Regeneron  Yahoo Finance

For Immediate Release. Chicago, IL –August 22, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity ...

Surging Earnings Estimates Signal Upside for Vertex (VRTX) Stock  Yahoo Finance

Vertex Pharmaceuticals (VRTX) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has ...

Is Vertex (VRTX) a Great Growth Stock?  Yahoo Finance

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Vertex (VRTX).

Vertex Pharmaceuticals (VRTX) Tops Q2 Earnings and Revenue Estimates  Yahoo Finance

Vertex (VRTX) delivered earnings and revenue surprises of 22.33% and 6.52%, respectively, for the quarter ended June 2019. Do the numbers hold clues to ...

Vertex to Profit $21B on Cystic Fibrosis Drug  Healthcare Packaging

A recent article from The Guardian discussed an aggressively priced cystic fibrosis drug that is on pace to earn its company $21 billion in profits. The drug is ...